The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by MarketWatch Top; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersNvidia’s board is investigating CEO Jensen Huang over his relationship with an alleged spy.
Why it mattersNvidia’s board is investigating CEO Jensen Huang over his relationship with an alleged spy.
Why it mattersFood and energy prices drove the consumer price index higher for October, likely keeping the Federal Reserve on track to raise interest rates next month. Grocery, gasoline and electricity prices all rose.
Food and energy prices drove the consumer price index higher for October, likely keeping the Federal Reserve on track to raise interest rates next month. Grocer…
Why it mattersThe probabilities make it almost certain that macro forecasts will be wrong far more often than right.